Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
ZLB Behring, L.L.C. | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
BAXTER HEALTHCARE CORP DBA BAXTER BIOSCIENCE | Takeda Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2011 | OSHA | $195,000 |
Schering-Plough Products, LLC | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | $260,000 |
Roche Molecular Systems, Inc. | Roche | pharmaceuticals | hazardous waste violation | 2011 | EPA | $90,000 |
MERCK & CO., INC. | Merck | pharmaceuticals | air pollution violation | 2011 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000 |
ELI LILLY AND COMPANY | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $337,500 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | air pollution violation | 2011 | EPA | $135,756 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $900,000 |
Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | FDA | $41,500,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
Eon Labs Inc. | Novartis | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | USAO | $149,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
ETHICON ENDO SURGERY | Johnson & Johnson | pharmaceuticals | aviation safety violation | 2010 | FAA | $5,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $6,500 |
MILLIPORE CORPORATION | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2010 | FAA | $15,000 |
Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | consumer protection violation | 2010 | KY-AG | $5,391,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Johnson & Johnson et al. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,454,432 |
Merck Sharp & Dohme Corp | Merck | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Laboratories Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
Par Pharmaceutical, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $500,000 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Purepac Pharmaceutical Co. | Pfizer | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Phibro-Tech Inc. | Phibro Animal Health | pharmaceuticals | hazardous waste violation | 2010 | CA-DTSC | $39,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | environmental violation | 2010 | CT-ENV | $31,266 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | hazardous waste violation | 2010 | NJ-ENV | $8,000 |
MERCK SHARP & DOHME CORP - RAHWAY NJ | Merck | pharmaceuticals | air pollution violation | 2010 | NJ-ENV | $6,000 |
Purdue Pharma L.P. | Purdue Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | private lawsuit-federal | $16,000,000 |
SCHWARZ PHARMA MANUFACTURING, INC. | UCB | pharmaceuticals | workplace safety or health violation | 2010 | OSHA | $6,750 |
EISAI INC. | Eisai | pharmaceuticals | workplace safety or health violation | 2010 | OSHA | $6,376 |
COVIDIEN DBA MALLINCKRODT INC. | Mallinckrodt | pharmaceuticals | workplace safety or health violation | 2010 | OSHA | $41,613 |
MILLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2010 | EPA | $526,500 |
Wyeth Pharmaceuticals Company, Inc. | Pfizer | pharmaceuticals | water pollution violation | 2010 | EPA | $77,000 |
Schering Plough Products, LLC | Merck | pharmaceuticals | environmental violation | 2010 | EPA | $11,500 |
Janssen Pharmaceutical (SB) | Johnson & Johnson | pharmaceuticals | environmental violation | 2010 | EPA | $105,000 |
Pfizer Pharmaceuticals | Pfizer | pharmaceuticals | PCB violation | 2010 | EPA | $24,650 |
AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Merck and Company, Inc. | Merck | pharmaceuticals | labor relations violation | 2009 | NLRB | $10,710 |
Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
Abbott Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Dey Labs | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
Immunex Corp. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |